At Tranquility Biodesign, we are pioneering a new class of microbial medicines designed to reshape how the immune system interacts with cancer. Our lead anti-cancer platform, SPIKEs, is an engineered therapeutic that directly targets solid tumors, remodels the tumor microenvironment, and boosts the power of immune-based treatments — all with a focus on safety, precision, and performance.